197 related articles for article (PubMed ID: 35141140)
1. Seven Genes Associated With Lymphatic Metastasis in Thyroid Cancer That Is Linked to Tumor Immune Cell Infiltration.
Wu L; Zhou Y; Guan Y; Xiao R; Cai J; Chen W; Zheng M; Sun K; Chen C; Huang G; Zhang X; Qian Z; Shen S
Front Oncol; 2021; 11():756246. PubMed ID: 35141140
[TBL] [Abstract][Full Text] [Related]
2. Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning.
Liu Y; Yin Z; Wang Y; Chen H
Front Endocrinol (Lausanne); 2023; 14():1247709. PubMed ID: 38144565
[TBL] [Abstract][Full Text] [Related]
3. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
4. Identification of key immune genes related to lymphatic metastasis of papillary thyroid cancer via bioinformatics analysis and experimental validation.
Yu Y; Guo X; Chai J; Han Z; Ji Y; Sun J; Zhang H
Front Oncol; 2023; 13():1181325. PubMed ID: 37274228
[TBL] [Abstract][Full Text] [Related]
5. Over-Expression and Prognostic Significance of FN1, Correlating With Immune Infiltrates in Thyroid Cancer.
Geng QS; Huang T; Li LF; Shen ZB; Xue WH; Zhao J
Front Med (Lausanne); 2021; 8():812278. PubMed ID: 35141255
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis for the identification of Sprouty-related EVH1 domain-containing protein 3 expression and its clinical significance in thyroid carcinoma.
Zhang X; Meng X; Wang P; Luan C; Wang H
Sci Rep; 2024 Feb; 14(1):4549. PubMed ID: 38402263
[TBL] [Abstract][Full Text] [Related]
7. Mining Prognostic Biomarkers of Thyroid Cancer Patients Based on the Immune-Related Genes and Development of a Reliable Prognostic Risk Model.
Fei H; Han X; Wang Y; Li S
Mediators Inflamm; 2023; 2023():6503476. PubMed ID: 37554551
[TBL] [Abstract][Full Text] [Related]
8. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract][Full Text] [Related]
9. Association of a Novel Prognosis Model with Tumor Mutation Burden and Tumor-Infiltrating Immune Cells in Thyroid Carcinoma.
Zhang S; Chen S; Wang Y; Zhan Y; Li J; Nong X; Gao B
Front Genet; 2021; 12():744304. PubMed ID: 34976004
[TBL] [Abstract][Full Text] [Related]
10. A biomarker and molecular mechanism investigation for thyroid cancer.
Xie K
Cent Eur J Immunol; 2023; 48(3):203-218. PubMed ID: 37901864
[TBL] [Abstract][Full Text] [Related]
11. Six Genes Associated with Lymphatic Metastasis in Colon Adenocarcinoma Linked to Prognostic Value and Tumor Immune Cell Infiltration.
Wang B; Yin C; Yang X; Shi H; Zhang Z; Zhou J; Zhang P
Evid Based Complement Alternat Med; 2022; 2022():4304361. PubMed ID: 36072412
[TBL] [Abstract][Full Text] [Related]
12. TTN mutations predict a poor prognosis in patients with thyroid cancer.
Han X; Chen J; Wang J; Xu J; Liu Y
Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35766333
[TBL] [Abstract][Full Text] [Related]
13. An Analysis of the Gene Expression Associated with Lymph Node Metastasis in Colorectal Cancer.
Yang H; Liu J; Jiang P; Li P; Zhou Y; Zhang Z; Zeng Q; Wang M; Xiao LX; Zhang X; Sun Y; Zhu S
Int J Genomics; 2023; 2023():9942663. PubMed ID: 37719786
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of BTNL9 as a prognostic biomarker correlated with immune infiltrations in thyroid cancer.
Zhang L; Yu S; Hong S; Xiao X; Liao Z; Li Y; Xiao H
BMC Med Genomics; 2023 Oct; 16(1):234. PubMed ID: 37798795
[TBL] [Abstract][Full Text] [Related]
15. New insights into COL26A1 in thyroid carcinoma: prognostic prediction, functional characterization, immunological drug target and ceRNA network.
Luo Y; Ye Y; Zhang Y; Chen L; Qu X; Yi N; Ran J; Chen Y
Transl Cancer Res; 2023 Dec; 12(12):3384-3408. PubMed ID: 38197076
[TBL] [Abstract][Full Text] [Related]
16. GDF10 and IDO1 as a thyroid cancer prognostic biomarker associated with immune infiltration.
Lv ZB; Zhang JJ; Xiang C
Heliyon; 2024 Mar; 10(6):e27651. PubMed ID: 38509876
[TBL] [Abstract][Full Text] [Related]
17. HSPA5 is a prognostic biomarker correlated with immune infiltrates in thyroid carcinoma.
Dong W; Du D; Huang H
Endokrynol Pol; 2022; 73(4):680-689. PubMed ID: 36059163
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of the prognosis and immune infiltration of E2Fs in thyroid carcinoma.
Fu X; Zhou X; Ji F; He Q; Qiu X
Front Genet; 2023; 14():1215984. PubMed ID: 37560385
[No Abstract] [Full Text] [Related]
19. Identification of Key Pathways and Genes Downstream of Insulin-Like Growth Factor 1 in Thyroid Carcinoma.
Wang J; Wu L; Lu W; Zhang H; Wu Y
Genet Test Mol Biomarkers; 2022 Nov; 26(11):522-531. PubMed ID: 36440844
[No Abstract] [Full Text] [Related]
20. Identification and validation of a glycolysis-related gene signature for predicting metastasis and survival rate in patients with thyroid cancer.
Wang B; Zhu Y; Zhang X; Wang Z
Transl Cancer Res; 2023 May; 12(5):1100-1111. PubMed ID: 37304543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
